{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Class:
CONCEPT
Status:
Investigational
Class:
CONCEPT
Status:
Investigational
Source:
INN:ERFONRILIMAB [INN]
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
INN:FIRZACORVIR [INN]
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT03620474: Phase 1/Phase 2 Interventional Recruiting Hepatitis C
(2018)
Source URL:
Class:
CONCEPT
Status:
Investigational
Class:
CONCEPT
Status:
Investigational
Source:
INN:NINERAFAXSTAT [INN]
Source URL:
Class:
CONCEPT
Status:
Investigational
Class:
CONCEPT
Status:
Investigational
Source:
INN:PLAZINEMDOR [INN]
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT04287985: Phase 2 Interventional Recruiting Immunoglobulin A Nephropathy
(2020)
Source URL:
Class:
CONCEPT